India Levetiracetam market is expected to grow at a significant rate during the forecast period. Levetiracetam drug is sold under the brand name Keppra, which is generally used to treat epilepsy by decreasing abnormal excitement in the brain. The India levetiracetam market is driven by use of this drug to treat partial onset seizures in adults and children who are at least 1 month old. Moreover, high incidence of epilepsy in India is forecasted to positively influence the market growth. Large number of clinical trials by key market players is further expected to boost the growth of India levetiracetam market through FY2027.

The India levetiracetam market is segmented based on source, form, distribution channel, treatment, route of administration, company, and region. Based on treatment, the market can be segmented into myoclonic treatment, tonic-clonic seizures treatment and others. Among these, myoclonic treatment segment is through FY2027 on account of growing prevalence of myoclonic epilepsy in the country. Moreover, the drug is effective for treating generalized tonic-clonic epilepsy, which is further boosting the segmental growth.

The major players operating in the India levetiracetam market are IPCA Laboratories Ltd., UCB India Pvt. Ltd., Cipla Limited, Ranbaxy Laboratories Ltd., Torrent Pharmaceuticals Ltd., Unichem Laboratories Ltd., Anuh Pharma Ltd., SVK Laboratories Private Limited, Jubilant Life Sciences Limited, Carise Phamaceuticals Pvt. Ltd., and others. Major companies are developing advanced technologies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions, research collaborations and new product developments to expand their geographic reach and to increase their customer basis.

Years considered for this report:

Historical Years: FY2017-FY2020

Base Year: FY2021

Estimated Year: FY2022

Forecast Period: FY2023–FY2027

Objective of the Study:

  • To analyze and estimate the market size of India levetiracetam market from FY2017 to FY2020.
  • To estimate and forecast the market size of India levetiracetam market from FY2021 to FY2027 and growth rate until FY2027.
  • To classify and forecast India levetiracetam market based on source, form, distribution channel, treatment, route of administration, company, and regional distribution.
  • To identify dominant region or segment in the India levetiracetam market.
  • To identify drivers and challenges for India levetiracetam market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India levetiracetam market.
  • To identify and analyze the profile of leading players operating in India levetiracetam market.
  • To identify key sustainable strategies adopted by market players in India levetiracetam market.

 

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India levetiracetam market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research. 

Key Target Audience:

  • Levetiracetam manufacturers/ suppliers/ distributors
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to levetiracetam

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India levetiracetam market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Levetiracetam Market, By Source:
    • In-house
    • Contract Manufacturing Organizations
  • India Levetiracetam Market, By Form:
    • Tablet
    • Syrup
    • Injection
  • India Levetiracetam Market, By Distribution Channel:
    • Online
    • Offline
  • India Levetiracetam Market, By Treatment:
    • Myoclonic Treatment
    • Tonic-Clonic Seizures Treatment
    • Others
  • India Levetiracetam Market, By Route of Administration:
    • Oral
    • Intravenous
  • India Levetiracetam Market, By Region:
    • North
    • South
    • East
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India levetiracetam market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India levetiracetam market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Levetiracetam Market

4.    Executive Summary

5.    Manufacturing Levetiracetam

5.1.  Raw Material

5.2.  Machinery

5.3.  Manufacturing Methods

5.4.  Contact Details of Machinery & Raw Material Suppliers

6.    Pharmacodynamic Overview of Levetiracetam

6.1.  Mechanism of Action

6.2.  Absorption

6.3.  Volume of Distribution

6.4.  Protein Binding

6.5.  Metabolism

6.6.  Route of Elimination

6.7.  Half-Life

6.8.  Clearance

6.9.  Toxicity

7.    India Levetiracetam Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Source (In-house v/s Contract Manufacturing Organizations)

7.2.2.     By Form (Tablet, Syrup, Injection)

7.2.3.     By Distribution Channel (Online v/s Offline)

7.2.4.     By Treatment (Myoclonic treatment, Tonic-clonic seizures treatment and Others)

7.2.5.     By Route of Administration (Oral v/s Intravenous)

7.2.6.     By Region (North, East, South, West)

7.2.7.     By Company

7.3.  Product Market Map

8.    Market Dynamics

8.1.  Drivers/Opportunities

8.2.  Challenges/Restraints

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

10.1.              Custom Duty & Taxes

10.2.              Government Subsidy & Benefits

10.3.              Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)

11.  Import & Export Analysis

12.  Pricing Analysis

13.  India Economic Profile

14.  Competitive Landscape

14.1.              Company Profiles

14.1.1.  IPCA Laboratories Ltd.

14.1.1.1.      Company Brief

14.1.1.2.      Production Plants & Capacity (If Available)

14.1.1.3.      Financials (If Available)

14.1.1.4.      Captive Consumption Vs Merchant Sale

14.1.1.5.      Current & Future Plans

14.1.2.  UCB India Pvt. Ltd.

14.1.3.  Cipla Limited

14.1.4.  Ranbaxy Laboratories Ltd.

14.1.5.  Torrent Pharmaceuticals Ltd.

14.1.6.  Unichem Laboratories Ltd.

14.1.7.  Anuh Pharma Ltd.

14.1.8.  SVK Laboratories Private Limited

14.1.9.  Jubilant Life Sciences Limited

14.1.10.                Carise Phamaceuticals Pvt. Ltd.

15.  Strategic Recommendations

16.  About Us & Disclaimer